Jiwei Ma
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 5
- Cancer Cells and Metastasis 3
- Co-authors
- Xueyun Zhong (9 shared papers)Haiying Li (4 shared papers)Shaoxiang Wang (5 shared papers)Yong Zhang (3 shared papers)Siming Xie (2 shared papers)Bin Du (1 shared paper)Ru Li (3 shared papers)Xiaoqian Zhai (1 shared paper)
- Journals
- Biomolecules & Therapeutics (1 paper)Medicine (1 paper)BioMed Research International (1 paper)Cancer Cell International (1 paper)Frontiers in Neurology (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jiwei Ma
28 papers receiving 478 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 72
- Geriatrics and Gerontology 14
- Genetics 37
- Toxicology 12
- Oncology 88
Countries citing papers authored by Jiwei Ma
This map shows the geographic impact of Jiwei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Ma more than expected).
Fields of papers citing papers by Jiwei Ma
This network shows the impact of papers produced by Jiwei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Ma. The network helps show where Jiwei Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiwei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 84 | |
| 2 | 2019 | 52 | |
| 3 | 2020 | 39 | |
| 4 | 2013 | 34 | |
| 5 | 2015 | 33 | |
| 6 | Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. | 2014 | 25 |
| 7 | 2015 | 23 | |
| 8 | 2016 | 21 | |
| 9 | 2016 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2019 | 17 | |
| 12 | 2020 | 15 | |
| 13 | 2016 | 14 | |
| 14 | 2015 | 13 | |
| 15 | 2019 | 11 | |
| 16 | 2018 | 9 | |
| 17 | 2020 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2022 | 6 | |
| 20 | 2014 | 6 |
About Jiwei Ma
Jiwei Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 481 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (3 papers), Cardiac Valve Diseases and Treatments (3 papers), Berberine and alkaloids research (3 papers), Glioma Diagnosis and Treatment (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Nitric Oxide and Endothelin Effects (1 paper) and Traumatic Brain Injury and Neurovascular Disturbances (1 paper). The work is most often cited by research in Cancer Research (72 citations), Geriatrics and Gerontology (14 citations), Genetics (37 citations), Toxicology (12 citations) and Oncology (88 citations). Jiwei Ma has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xueyun Zhong, Haiying Li, Shaoxiang Wang, Yong Zhang, Siming Xie, Bin Du, Ru Li, Xiaoqian Zhai, Pu Zhang and Xiaoyan Fu. Their work appears in journals such as Biomolecules & Therapeutics, Medicine, BioMed Research International, Cancer Cell International and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.